← Back to headlines
Johnson & Johnson Advances Bladder Cancer Treatment with High Response Rate
Johnson & Johnson (JNJ) has made significant progress in its bladder cancer treatment, reporting an impressive 89% response rate in recent trials. This development offers new hope for patients.
24 Mar, 11:27 — 24 Mar, 11:27
Sources
Showing 1 of 1 sources
